Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 36.00 | |
50 mg | In stock | $ 52.00 | |
100 mg | In stock | $ 81.00 | |
200 mg | In stock | $ 123.00 | |
500 mg | In stock | $ 189.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 39.00 |
Description | Moxifloxacin hydrochloride (BAY12-8039 HCl) is a fourth generation fluoroquinolone with expanded activity against gram-positive bacteria as well as atypical pathogens. Moxifloxacin has been linked to mild ALT elevations during therapy and to rare instances of idiosyncratic acute liver injury with symptoms and jaundice. |
Synonyms | BAY-128039, Moxifloxacin HCl, BAY12-8039 HCl |
Molecular Weight | 437.89 |
Formula | C21H25ClFN3O4 |
CAS No. | 186826-86-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 15 mg/mL(34.3 mM)
DMSO: 88 mg/mL (200.96 mM)
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Moxifloxacin hydrochloride 186826-86-8 DNA Damage/DNA Repair Microbiology/Virology Topoisomerase Antibacterial Antibiotic Moxifloxacin exacerbations bronchitis BAY 128039 community-acquired chronic acute BAY-128039 Moxifloxacin Hydrochloride sinusitis BAY128039 antimicrobial BAY 12-8039 Bacterial inhibit Moxifloxacin HCl 8-methoxyquinolone BAY12-8039 HCl Inhibitor pneumonia inhibitor